Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second-line Therapy”

1,267 trials

Showing 20 of 1,267 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02657551
What this trial is testing

A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Dana-Farber Cancer Institute 8
Not applicableUnknownNCT01650766
What this trial is testing

Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers

Who this might be right for
Gastric Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 80
Testing effectiveness (Phase 2)Ended earlyNCT02452970
What this trial is testing

RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy

Who this might be right for
Cholangiocarcinoma
EpicentRx, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT00778102
What this trial is testing

Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 80
Testing effectiveness (Phase 2)Study completedNCT00444587
What this trial is testing

Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 114
Not applicableUnknownNCT00336206
What this trial is testing

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Tawam Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07540832
What this trial is testing

Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang Haichang Biotech Co., Ltd. 80
Large-scale testing (Phase 3)Study completedNCT01160211
What this trial is testing

Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 369
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01124864
What this trial is testing

AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.

Who this might be right for
Non-small-cell Lung Cancer
Novartis Pharmaceuticals 153
Testing effectiveness (Phase 2)Study completedNCT00940316
What this trial is testing

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Northwestern University 28
Testing effectiveness (Phase 2)Study completedNCT01943864
What this trial is testing

A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers

Who this might be right for
Cancer
GlaxoSmithKline 20
Not applicableStudy completedNCT03896984
What this trial is testing

Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Bayer 346
Testing effectiveness (Phase 2)UnknownNCT03778138
What this trial is testing

Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC

Who this might be right for
Non-squamous Cell Non-Small Cell Lung Cancer
Henan Provincial People's Hospital 51
Not applicableStudy completedNCT04957160
What this trial is testing

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Ipsen 281
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495579
What this trial is testing

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Asan Medical Center 146
Testing effectiveness (Phase 2)Study completedNCT01273662
What this trial is testing

Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 45
Not applicableUnknownNCT02618590
What this trial is testing

A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 800
Testing effectiveness (Phase 2)UnknownNCT05965154
What this trial is testing

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 22
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation